IQVIA Holdings | IQV - Selling And Administration Expenses

Stock Price
165.62
Daily Change
-3.74 -2.21%
Monthly
-31.39%
Yearly
-13.31%
Q1 Forecast
160.49

IQVIA Holdings reported $468M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Accenture USD 3.02B 69.96M Sep/2025
Agilent USD 428M 37M Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cigna USD 3.19B 242M Sep/2025
Cognizant Technology Solutions USD 806M 27M Dec/2025
Computer Programs Systems USD 161.36M 1.74M Sep/2025
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Elevance Health USD 10.91B 309M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Humana USD 3.36B 614M Mar/2025
IBM USD 5.82B 722M Dec/2025
Illumina USD 283M 27M Dec/2025
Infosys INR 10.82B 10.32B Dec/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 2.03B 44M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Ovoca Bio EUR 2.96M 8K Jun/2022
Pharma Mar EUR 13.7M 983K Sep/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
Quest Diagnostics USD 504M 3M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Tilray USD 24.85M 1.7M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veeva Systems USD 128.19M 9.41M Sep/2025
Veradigm USD 32.52M 27.13M Sep/2022
Waters USD 240.01M 25.78M Dec/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025